May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Expression of Matrix Metalloproteinase-3 in the Sclera and Trabecular Meshwork of Glaucoma Patients with Uveitis
Author Affiliations & Notes
  • K. Kobayashi
    Department of Ophthalmology, Saga Medical School, Saga, Japan
  • R. Iwakiri
    Department of Ophthalmology, Saga Medical School, Saga, Japan
  • J. Nakabayashi
    Department of Ophthalmology, Saga Medical School, Saga, Japan
  • H. Kobayashi
    Department of Ophthalmology, Saga Medical School, Saga, Japan
  • S. Okinami
    Department of Ophthalmology, Saga Medical School, Saga, Japan
  • Footnotes
    Commercial Relationships  K. Kobayashi, None; R. Iwakiri, None; J. Nakabayashi, None; H. Kobayashi, None; S. Okinami, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1419. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Kobayashi, R. Iwakiri, J. Nakabayashi, H. Kobayashi, S. Okinami; Expression of Matrix Metalloproteinase-3 in the Sclera and Trabecular Meshwork of Glaucoma Patients with Uveitis . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1419.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Matrix metalloproteinases (MMPs) are involved in tissue remodeling, which is one of the most important aspects of inflammatory disease. This study was undertaken to investigate the expression of matrix metalloproteinases (MMPs) and tissue inhibitor of MMP (TIMP) in the sclera and trabecular meshwork of glaucoma patients with uveitis. Methods: Trabeculectomy specimens of 4 patients with uveitis and those of 6 patients with primary open angle glaucoma and those of 2 patients with angle closure glaucoma were examined. Immunohistochemistry using frozen sections was performed with antibodies to MMP-1, MMP-2, MMP-3, MMP-9, and TIMP-1. Results: MMP-3 was detected in all specimens of patients with uveitis. The intensity of the immunostaining for MMP-3 was greater in the sclera and trabecular meshwork of glaucoma patients with uveitis compared with those of primary open angle glaucoma and angle closure glaucoma patients. No significant difference was found in the intensity of the immunostaining for MMP-1, MMP-2, MMP-9 and TIMP-1 among the specimens of patients with uveitis, primary open angle glaucoma, and angle closure glaucoma. Conclusions: There is increased immunostaining for MMP-3 in the sclera and trabecular meshwork of glaucoma patients with uveitis, which suggests increased expression of MMP-3 in uveitis and thereby implies a role in the tissue remodeling seen in the sclera and trabecular meshwork with uveitis.

Keywords: immunohistochemistry • trabecular meshwork • uveitis-clinical/animal model 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×